Susanne Sprung

1.1k total citations
30 papers, 456 citations indexed

About

Susanne Sprung is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Susanne Sprung has authored 30 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Susanne Sprung's work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer-related molecular mechanisms research (4 papers). Susanne Sprung is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer-related molecular mechanisms research (4 papers). Susanne Sprung collaborates with scholars based in Austria, Germany and Spain. Susanne Sprung's co-authors include Christian Marth, Alain G. Zeimet, Heidi Fiegl, Verena Wieser, Giridhar Shivalingaiah, Sigurd Lax, József Dudás, Andreas Pircher, Irina Tsibulak and Andrea Brunner and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Susanne Sprung

28 papers receiving 451 citations

Peers

Susanne Sprung

ONCOL

IMMUN

SURGE

Kuo‐Chang Wen Taiwan

Pauline Athanassiadou Greece

Melissa S. DeRycke United States

Micaela Morgado United States

Thomas Löning Germany

Emilia Andersson Sweden

Nelson S.S. Siu Hong Kong

SHOJIRO YANO Japan

Omar López-Ocejo Cuba

Diana Handke Germany

Kuo‐Chang Wen Taiwan

Susanne Sprung

102 ×0.5

ONCOL

216 ×1.1

99 ×0.8

63 ×0.7

IMMUN

78 ×1.1

SURGE

Citations per year, relative to Susanne Sprung Susanne Sprung (= 1×) peers Kuo‐Chang Wen

Countries citing papers authored by Susanne Sprung

Since Specialization

Citations

This map shows the geographic impact of Susanne Sprung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Sprung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Sprung more than expected).

Fields of papers citing papers by Susanne Sprung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne Sprung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Sprung. The network helps show where Susanne Sprung may publish in the future.

Co-authorship network of co-authors of Susanne Sprung

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne Sprung. A scholar is included among the top collaborators of Susanne Sprung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne Sprung. Susanne Sprung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sprung, Susanne, et al.. (2024). Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy. Frontiers in Immunology. 15. 1489235–1489235. 1 indexed citations

Dudás, József, Daniel Dejaco, Teresa Bernadette Steinbichler, et al.. (2024). Cytotoxic response of tumor-infiltrating lymphocytes of head and neck cancer slice cultures under mitochondrial dysfunction. Frontiers in Oncology. 14. 1364577–1364577.

Sprung, Susanne, Christian F. Freyschlag, Romana Hoeftberger, et al.. (2023). Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide. International Journal of Molecular Sciences. 24(7). 6184–6184. 7 indexed citations

Amann, Arno, Marit Zwierzina, Edith Lorenz, et al.. (2023). Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC. OncoImmunology. 12(1). 2274130–2274130. 4 indexed citations

Schwaiger, Theresa, Susanne Sprung, Paolo Chetta, et al.. (2022). Patient-derived head and neck tumor slice cultures: a versatile tool to study oncolytic virus action. Scientific Reports. 12(1). 15334–15334. 13 indexed citations

Fiegl, Heidi, Judith Hagenbuchner, Beata Seeber, et al.. (2022). Dubious effects of methadone as an “anticancer” drug on ovarian cancer cell-lines and patient-derived tumor-spheroids. Gynecologic Oncology. 165(1). 129–136. 3 indexed citations

Eshwaraiah, Mallikarjuna Siraganahalli, Cristina Saura, Patricia Gómez, et al.. (2022). A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort. The Breast. 63. 1–8. 9 indexed citations

Ingruber, Julia, Dragana Savic, Teresa Bernadette Steinbichler, et al.. (2021). KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma. Cells. 10(3). 539–539. 22 indexed citations

Pizzini, Alex, Magdalena Aichner, Ivan Tancevski, et al.. (2021). High expression of mTOR signaling in granulomatous lesions is not predictive for the clinical course of sarcoidosis. Respiratory Medicine. 177. 106294–106294. 11 indexed citations

10.

Steinbichler, Teresa Bernadette, József Dudás, Julia Ingruber, et al.. (2020). Slug Is A Surrogate Marker of Epithelial to Mesenchymal Transition (EMT) in Head and Neck Cancer. Journal of Clinical Medicine. 9(7). 2061–2061. 31 indexed citations

11.

Tsibulak, Irina, Verena Wieser, Giridhar Shivalingaiah, et al.. (2020). The miR-34 family and its clinical significance in ovarian cancer. Journal of Cancer. 11(6). 1446–1456. 41 indexed citations

12.

Dudás, József, Christian Pritz, Teresa Bernadette Steinbichler, et al.. (2019). Brain-Derived Neurotrophin and TrkB in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. 20(2). 272–272. 10 indexed citations

13.

Wolf‎, Dominik, Heidi Fiegl, Alain G. Zeimet, et al.. (2019). High RIG‐I expression in ovarian cancer associates with an immune‐escape signature and poor clinical outcome. International Journal of Cancer. 146(7). 2007–2018. 38 indexed citations

14.

Pichler, Renate, Josef Fritz, Susanne Sprung, et al.. (2018). Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk Patients. Clinical Genitourinary Cancer. 16(5). e1015–e1024. 13 indexed citations

15.

Laimer, Johannes, Raphael Henn, Susanne Sprung, et al.. (2018). Amalgam tattoo versus melanocytic neoplasm - Differential diagnosis of dark pigmented oral mucosa lesions using infrared spectroscopy. PLoS ONE. 13(11). e0207026–e0207026. 7 indexed citations

16.

Tsibulak, Irina, Verena Wieser, Giridhar Shivalingaiah, et al.. (2018). BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer. British Journal of Cancer. 119(6). 683–692. 32 indexed citations

17.

Gamerith, Gabriele, Hubert Hackl, Jeffrey C. Kern, et al.. (2018). Soluble immune checkpoints CD27, Lag3, PD-L2 and Tim3 in early stage NSCLC patients. European Journal of Cancer. 92. S12–S12. 1 indexed citations

18.

Wieser, Verena, Giridhar Shivalingaiah, Susanne Sprung, et al.. (2018). BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer. Oncotarget. 9(25). 17501–17511. 68 indexed citations

19.

Azim, Samira Abdel, Susanne Sprung, Irene Mutz‐Dehbalaie, et al.. (2017). L1CAM and HER2 Expression in Early Endometrioid Uterine Cancer. International Journal of Gynecological Pathology. 36(4). 356–363. 8 indexed citations

20.

Azim, Samira Abdel, Susanne Sprung, Daniel Reimer, et al.. (2016). Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer. Oncotarget. 7(24). 37205–37214. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact